1. Startup Package, University of Connecticut.: 2007
  2. Connecticut Research Foundation: Experiments & Simulations to Characterize Tablet Coating Process, Jun 2007 to May 2009.
  3. NSF-Center of Pharmaceutical Processing Research: Numerical Modeling, Optimization and Scale-up of Pharmaceutical Milling in a Hammer mill, Jan 2010 to Dec 2011.
  4. Connecticut Research Foundation: Experimentally validated numerical modeling of electrostatic effects in granular media, Jan 2010 to Dec 2010
  5. University of Connecticut: Travel Grant, July 2009
  6. NSF-Center for Pharmaceutical Processing and Research/Pfizer Inc.: Quantifying Drying Performance of a Filter Dryer, Experiments, and Simulation, July 2008 to Dec 2010
  7. University of Connecticut: Travel Grant 2010
  8. Boehringer Ingelhiem Pharmaceutical Inc. (BIPI): Computer Modeling of Pharmaceutical Manufacturing Processes, Jan 2011 – Dec 2011
  9. PhRMA Foundation Starter Grant: Experimentally validated Modeling, Optimization, and Scale-up of High Shear Wet Granulation Process, Jan 2011 to May 2012
  10. Boehringer Ingelhiem Pharmaceutical Inc.(BIPI): Pharmaceutical Powder Modeling and Technology, Jan 2012 – Dec 2012
  11. US-Food and Drug Administration (FDA-NIPTE): Modeling of Aerodynamic Flow through MDI Spacer (VHC) and Characterization of Aerodynamic Particle Size Distribution using alternate methods, March 2012 to July 2013
  12. Pfizer Inc.: Investigation of Electrostatic Behavior of Pharmaceutical Formulations, Sept 2012 to Aug 2014
  13. Physical Sciences Incorporated (PSI) (subcontract from Phase 1 SBIR Grant from NIH): Organic Solvent Vapor Mass Flow Rate Monitor for Pharmaceutical Drying Operations, Sept 2012 to Aug 2013
  14. NSF-Center for Pharmaceutical Processing and Research/AstraZeneca: Investigation of Mixing and Segregation in Dry Powder Inhaler (DPI) Formulations, March 2013 to February 2015
  15. US-Food and Drug Administration (FDA-NIPTE): Young Investigator Award (YIA) – Understanding Electrostatic Behavior in Granular Materials: Multi-scale Models and Experiments, January 2013 to December 2014
  16. NSF-Center for Pharmaceutical Processing and Research: Porous materials as excipients for solid self-nano emulsifying drug delivery systems, (PI: Lu, Co-PI: Chaudhuri) July 2014 to June 2016
  17. NSF-Center for Pharmaceutical Processing and Research: Experimentally validated computational process models to predict the flow properties of pharmaceutical powders under different humidity conditions, August 2015 to July 2017
  18. American Cancer Society: Activatable nanoparticles for radiotherapy of metastatic ovarian cancer, (PI: Lu, Collaborator: Chaudhuri), July 2015 to June 2019
  19. US-Food and Drug Administration (FDA/NIPTE): A QbD approach to process development: Defining critical quality attributes, evaluating criticality across scales, and relating variation in CPPS/CQAS to product performance, (PI: Jim Drennen, CoPI: Chaudhuri), August 2015 to July 2017
  20. NSF- I/UCRC:  Science of Heterogeneous Additive Printing of 3D Materials (SHAP3D), Timeline: 1/1/2017 – 12/31/2022, PI: Anson Ma (CBE), Collaborator: Chaudhuri.
  21. Genentech: 3D printing for solid dosage form, Timeline: 07/01/17 – 06/30/20, PI (s): Chaudhuri, , Anson Ma (CBE).
  22. NSF-CPPR: Inkjet based 3D printing for solid oral dosage manufacturing, PI: Chaudhuri, Co-PI: Anson Ma (CBE), Aug 2017 to July 2019.
  23. US Food and Drug Administration (FDA): Co-PI: B. Chaudhuri, PI: Diane Burgess, A continuous manufacturing platform for complex dosage form, September 2017 to August 2020.
  24. Pfizer: PI(s): B. Chaudhuri, PI: Anson Ma (CBE), Characterization and 3D printing of placebo and modified release tablets. July 2017 to June 2018.
  25. NSF-CPPR: PI: Chaudhuri, Co-PI: R.Bogner, T. Fan (ME), Development of a scaled down model for freeze-thaw of biologics applying a DOE approach, January 2018 to Aug 2019.
  26. NSF-CPPR: PI: Chaudhuri, Experimentally validated CFD-DEM model of multicomponent, multiphase flow modeling of a fluidized bed dryer, January 2019 to December 2020.
  27. Takeda Pharmaceuticals: PI: Chaudhuri, Development of a CFD-DEM model of Pharmaceutical Unit Operations, September 2019 to March 2020.
  28. UConn- START PPOC Grant, June’2020 to May’2021.
  29. Takeda Pharmaceuticals: PI: Chaudhuri, Development of a CFD-DEM model of Tablet Dissolution Process, April 2020 to October 2020.
  30. Genentech: 3D printing for solid dosage forms, Timeline: 11/01/20 – 10/31/22, PI (s): Chaudhuri, , Anson Ma (CBE).
  31. Takeda Pharmaceuticals: PI: Chaudhuri, Applicability and calibration of CFD-DEM model for pharmaceutical processes, November 2020 to October 2021.
  32. Sarepta Therapeutics: Molecular modeling of AAV aggregation and their interaction with hydrophobic surfaces, September 2021 to May 2023.
  33. NSF-CPPR: PI: Chaudhuri, Understanding the role of binder-excipient interaction in continuous wet granulation processes using experimentally validated computer modeling, January 2022 to December 2024.
  34. UConn OVPR : PI: B. Chaudhuri, Co-PI: Yu Lei, Yangchao Lu, Matthew Stuber, Research Excellence Program – Continuous manufacturing of drug product for pulmonary drug delivery
  35. Sarepta Therapeutics:PI: B. Chaudhuri, Molecular Modeling of AAV Capsid-capsid interaction under different salt concentrations, surfactants, and shear stress, May’2023 to May’2024.
  36. NSF-CPPR: PI: B. Chaudhuri, Experimentally Validated CFD-DEM Based Model Of Multiphase Mixing Of Suspensions In A HyPerforma Mixer. Jan’2024 to Dec’2025
  37. Aerosol Society PI: B. Chaudhuri, Co-PI: T. Mehta, Effect of process parameters on Dry Powder Inhaler (DPI) Performance. Dec’2023 to Dec’2024